PCR-Based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells.
about
A series of diaryltriazines and diarylpyrimidines are highly potent nonnucleoside reverse transcriptase inhibitors with possible applications as microbicidesHuman immunodeficiency virus type 1 (HIV-1) proviral DNA load in purified CD4+ cells by LightCycler real-time PCR.Different patterns of HIV-1 DNA after therapy discontinuation.Humanized mice recapitulate key features of HIV-1 infection: a novel concept using long-acting anti-retroviral drugs for treating HIV-1Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infectionLow human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions.Simple, sensitive, and specific detection of human immunodeficiency virus type 1 subtype B DNA in dried blood samples for diagnosis in infants in the fieldQuantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assayQuantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA loadQuantification of human immunodeficiency virus type 1 proviral DNA by using TaqMan technology.Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistenceIn vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides.Comparative Analysis of Cell-Associated HIV DNA Levels in Cerebrospinal Fluid and Peripheral Blood by Droplet Digital PCRHIV-1 proviral DNA loads (as determined by quantitative PCR) in patients subjected to structured treatment interruption after antiretroviral therapy failure.Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy.Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ARTMeasuring the latent reservoir in vivo.Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-up.Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy.Association of CD4+ T-lymphocyte counts and new thymic emigrants in HIV-infected children during successful highly active antiretroviral therapyCpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo.Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications.Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years.Quantification of Total and 2-LTR (Long terminal repeat) HIV DNA, HIV RNA and Herpesvirus DNA in PBMCs.Development and assessment of a multiplex real-time PCR assay for quantification of human immunodeficiency virus type 1 DNA.The Use of Ultra-Sensitive Molecular Assays in HIV Cure-Related Research.
P2860
Q24563844-389B8332-5329-4AF2-9A66-9BA7020E4378Q24811629-95539B21-2385-458E-A547-829138E99AC0Q24816681-106C9D8D-98E4-4233-8C7C-C464926C5AC3Q28728527-001D08DE-BE7A-4520-BE22-4AFD756AC9D5Q28748901-37D9CA52-8850-4D3E-9A2B-EAEAD40E8D9DQ33883813-24CCCA4F-8402-4C51-BBEC-E8A874CE910EQ33970771-91530AED-E7AB-4414-ACBF-31CE0FF2C3AAQ33971820-23394488-91B5-4D9A-9599-BD69379A77EEQ34348055-AFE55CD5-7A3D-472B-B30B-AE1BFC2FA557Q34943329-90FC52F2-45D0-48BD-9478-B59840A61239Q34960856-14945438-5C83-44B8-B3DC-643D0FFBC6ABQ35006752-79088415-734F-42F2-9625-477B8E82A513Q35797131-1DB33290-FFAC-41FF-A838-7E19F464BA6AQ36022975-C25E2C44-B3D3-4C53-8146-007B5D3BC0CAQ36098975-3C65F828-6E2F-42A5-9937-3C5B6FCF90ABQ36313228-40FB9B7C-0A21-40BD-BE2B-1527D2EE8FBFQ36316590-CB7535F7-DE5E-499D-BD6B-B71D368682E4Q36515110-6A477839-CE56-4E48-AD81-0BEC02EB1D57Q37037090-0D783402-2529-41C6-88C4-74C68C72C4ADQ37354047-C4F038BA-F819-4A80-8136-FB5E5E88B06CQ37374972-CCDA2625-3866-4AC2-9C63-70F9199A2CE5Q37596720-5C767677-768F-4F22-B74E-429527CC0D88Q38936786-AFC52B38-5FF0-46A7-AC89-E84208F2B7C2Q39997616-F4267A29-E968-4C4D-948E-BDDC3028ACC3Q40394431-A50C5225-F517-45EC-B088-EE7CA41DE758Q41985867-5574EB74-513C-4BBD-889F-84BCF7BA849DQ42037424-44070E8E-9C5F-4804-8863-CDB0CB5708D4
P2860
PCR-Based assay to quantify human immunodeficiency virus type 1 DNA in peripheral blood mononuclear cells.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
PCR-Based assay to quantify hu ...... heral blood mononuclear cells.
@en
PCR-Based assay to quantify hu ...... heral blood mononuclear cells.
@nl
type
label
PCR-Based assay to quantify hu ...... heral blood mononuclear cells.
@en
PCR-Based assay to quantify hu ...... heral blood mononuclear cells.
@nl
prefLabel
PCR-Based assay to quantify hu ...... heral blood mononuclear cells.
@en
PCR-Based assay to quantify hu ...... heral blood mononuclear cells.
@nl
P2093
P2860
P1476
PCR-Based assay to quantify hu ...... heral blood mononuclear cells.
@en
P2093
P2860
P304
P407
P577
2000-02-01T00:00:00Z